Critical Limb Ischemia Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

May 2019| TMR1602A| Transparency

Report Highlights

Global Critical Limb Ischemia Treatment Market: Overview

This report analyzes the current and future scenario of the global critical limb ischemia treatment market. Increase in patient population with critical limb ischemia, growth of the pharmaceutical industry, improvement in health care infrastructure, and increase in the number of clinical trials are projected to be the major drivers of the global market during the forecast period.

The global critical limb ischemia treatment market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on treatment, and region. A detailed qualitative analysis of drivers and restraints of the market, and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by region and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global critical limb ischemia treatment market.

Global Critical Limb Ischemia Treatment Market: Key Segments

Based on treatment, the global critical limb ischemia treatment market has been segmented into devices and medications. The segments have been analyzed based on available devices and drug products used in the treatment of critical limb ischemia, cost-effectiveness, and preference for industries. The market size and forecast for each of these segments have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year.

Global Critical Limb Ischemia Treatment Market: Regional Outlook

In terms of region, the global critical limb ischemia treatment market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries/sub-regions have been provided for the period from 2017 to 2027, along with their respective CAGRs for the forecast period from 2019 to 2027, considering 2018 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global critical limb ischemia treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. The major players profiled in the market report include Medtronic plc, Boston Scientific Corporation, Cesca Therapeutics, Inc., Abbott Laboratories, Pluristem Therapeutics, Inc., Rexgenero Ltd., LimFlow SA, Micro Medical Solutions, and Cardiovascular Systems, Inc.

The global critical limb ischemia treatment market has been segmented as below:

Global Critical Limb Ischemia Treatment Market, by Treatment
Devices
Embolic Protection Devices
Peripheral Dilatation Systems
Balloon Dilators
Vascular stents
Medications
Antiplatelet Drugs
Antihypertensive Agents
Lipid-lowering Agents
Antithrombotic Agents
Others

Global Critical Limb Ischemia Treatment Market, by Region
North America
U.S.
Canada
Europe
Germany
U.K.
Italy
France
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Australia & New Zealand
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Rest of Middle East & Africa

  • Table 1 : Pipeline Analysis
  • Table 2 : Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 3 : Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 4 : Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 5 : Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 6 : Global Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Region,2017-2027
  • Table 7 : North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country,2017-2027
  • Table 8 : North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 9 : North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices,2017-2027
  • Table 10 : North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems,2017-2027
  • Table 11 : North America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications,2017-2027
  • Table 12 : Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 13 : Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 14 : Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices,2017-2027
  • Table 15 : Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems,2017-2027
  • Table 16 : Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications,2017-2027
  • Table 17 : Asia Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 18 : Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 19 : Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices,2017-2027
  • Table 20 : Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems,2017-2027
  • Table 21 : Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications,2017-2027
  • Table 22 : Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 23 : Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 24 : Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices,2017-2027
  • Table 25 : Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems,2017-2027
  • Table 26 : Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications,2017-2027
  • Table 27 : Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Country/Sub-region,2017-2027
  • Table 28 : Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Treatment,2017-2027
  • Table 29 : Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Devices,2017-2027
  • Table 30 : Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Peripheral Dilatation Systems,2017-2027
  • Table 31 : Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) Forecast, by Medications,2017-2027
  • Table 32 : Medtronic plc, Business Overview
  • Table 33 : Boston Scientific Corporation Product Offerings
  • Table 34 : Cesca Therapeutics, Inc., Products & Services Offered
  • Table 35 : Abbott Laboratories, Business Overview
  • Table 36 : Pluristem Therapeutics, Inc., Products & Services Offered
  • Table 37 : Rexgenero Ltd., Products & Services Offered
  • Table 38 : LimFlow SA, Products & Services Offered
  • Table 39 : Micro Medical Solutions, Products & Services Offered
  • Table 40 : Cardiovascular Systems, Inc., Products & Services Offered
  • Figure 1 : Global Critical Limb Ischemia Treatment Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
  • Figure 2 : Global Critical Limb Ischemia Treatment Market Revenue Projection (US$ Mn),2017-2027
  • Figure 3 : Global Critical Limb Ischemia Treatment Market Value Share, by Treatment, 2018
  • Figure 4 : Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2018
  • Figure 5 : U.S. FDA Medical Devices Approval Criteria
  • Figure 6 : Classification of Medical Devices
  • Figure 7 : European Approval for Medical Devices - Regulatory Pathway (Class IIb Devices only)
  • Figure 8 : Regulatory Approval Process - U.S.
  • Figure 9 : Regulatory Approval Process - Europe
  • Figure 10 : Regulatory Approval Process - Japan
  • Figure 11 : Prevalence of Critical Limb Ischemia Globally/Region
  • Figure 12 : Global Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 13 : Global Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 14 : Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Devices,2017-2027
  • Figure 15 : Global Critical Limb Ischemia Treatment Market Value (US$ Mn) and Y-o-Y Growth, by Medications,2017-2027
  • Figure 16 : Global Critical Limb Ischemia Treatment Market Scenario, by Country
  • Figure 17 : Global Critical Limb Ischemia Treatment Market Value Share, by Region, 2018 and 2027
  • Figure 18 : Global Critical Limb Ischemia Treatment Market Attractiveness, by Region, 2019–2027
  • Figure 19 : North America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
  • Figure 20 : North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country, 2018 and 2027
  • Figure 21 : North America Critical Limb Ischemia Treatment Market Attractiveness, by Country, 2019–2027
  • Figure 22 : North America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 23 : North America Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 24 : Europe Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
  • Figure 25 : Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 26 : Europe Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 27 : Europe Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 28 : Europe Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 29 : Asia Pacific Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
  • Figure 30 : Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 31 : Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 32 : Asia Pacific Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 33 : Asia Pacific Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 34 : Latin America Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
  • Figure 35 : Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 36 : Latin America Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 37 : Latin America Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 38 : Latin America Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 39 : Middle East & Africa Critical Limb Ischemia Treatment Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2019–2027
  • Figure 40 : Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
  • Figure 41 : Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness, by Country/Sub-region, 2019–2027
  • Figure 42 : Middle East & Africa Critical Limb Ischemia Treatment Market Value Share Analysis, by Treatment, 2018 and 2027
  • Figure 43 : Middle East & Africa Critical Limb Ischemia Treatment Market Attractiveness, by Treatment, 2019–2027
  • Figure 44 : Medtronic plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 45 : Medtronic plc, Breakdown of Net Sales (%), by Geography, 2018
  • Figure 46 : Medtronic plc, Breakdown of Net Sales (%), by Business Segment, 2018
  • Figure 47 : Medtronic plc, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 48 : Boston Scientific Corporation, Revenue (US$ Bn) and Y-o-Y Growth (%), 2014–2017
  • Figure 49 : Boston Scientific Corporation, Breakdown of Net Sales, by Region, 2017
  • Figure 50 : Boston Scientific Corporation, Breakdown of Net Sales, by Business Segment, 2017
  • Figure 51 : Cesca Therapeutics Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
  • Figure 52 : Cesca Therapeutics Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
  • Figure 53 : Cesca Therapeutics Inc. Breakdown of Net Sales, by Region, 2018
  • Figure 54 : Cesca Therapeutics Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2016–2018
  • Figure 55 : Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
  • Figure 56 : Abbott Laboratories, R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2016–2018
  • Figure 57 : Abbott Laboratories, Breakdown of Net Sales, by Countries, 2018
  • Figure 58 : Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2018
  • Figure 59 : Cardiovascular Systems, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
  • Figure 60 : Cardiovascular Systems, Inc. R&D Intensity and Sales & Marketing Intensity (US$ Mn), 2016–2018

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report